GPBAR1 and myocardial infarction: The study also found that compared with the control group, the ischemic damage to cardiac function of MI mice treated with DCA was reduced, and the main mechanism was to reduce inflammation through dca-tgr5 signaling pathway to improve cardiac function after myocardial infarction.